VOLANTINO ContiamoCi!: fonti e approfondimenti
Pubblicato il 25 Agosto 2021
1. Posso INFETTARMI e CONTAGIARE al pari di un NON VACCINATO.
- 1.1 Delta infections associated with higher viral load and duration of shedding_ Published evidence
- 1.2 Early Release – Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021 – Volume 27, Number 10—October 2021 – Emerging Infectious Diseases journal – CDC
- 1.3 Elapsed time since BNT162b2 vaccine and risk of SARS- CoV-2 infection in a large cohort
- 1.4 Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- 1.5 REACT-1 round 12 report_ resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant
- 1.6 Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent – Wisconsin, July 2021 _ medRxiv
- 1.7 The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
- 1.8 Transmission of SARS-CoV-2 Delta variant among vaccinated healthcare workers, Vietnam
2. Devo continuare ad indossare la MASCHERINA ed a mantenere il DISTANZIAMENTO
- 2.1 Interim Public Health Recommendations for Fully Vaccinated People _ CDC
- 2.2 AIFA 4 agosto 2021 Domande e risposte sui vaccini COVID-19
- 2.3 Rapporto ISS COVID 2_ Protezioni_REV.V6
- 2.4 Efficacy of face mask in preventing respiratory virus transmission- A systematic review and meta-analysis
3. Vi sono GRAVI EFFETTI COLLATERALI A BREVE TERMINE
- 3.1 Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
- 3.2 Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.pdf
- 3.3 Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease
- 3.4 Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
- 3.5 Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
- 3.6 10272-Article Text-75359-2-10-20210728
- 3.7 Astrazeneca e trobosi
- 3.8 Journal of Neurology (content)
- 3.9 Eeffetti avversi vaccini
4. E’ un FARMACO SPERIMENTALE, del quale sono sconosciuti gli EFFETTI a MEDIO e LUNGO TERMINE
- 4.1 Adverse Consequences of Rushing a SARS-CoV-2 Vaccine- Implications for Public Trust _ Vaccination _ JAMA _ JAMA Network
- 4.2 covid19_rna_based_vaccines_and_the_risk_of_prion_disease_1503
- 4.3 covid19-vaccine-associated-parkinsons-disease-a-prion-disease-signal-in-the-uk-yellow-card-adverse-event-database-1746
- 4.4 Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
- 4.5 The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and 2 innate immune responses
5. VACCINARE DURANTE UNA PANDEMIA
- 5.1 Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan_D614G strain and Delta variants. A potential risk for mass vaccination
- 5.2 SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2- Cell
- 5.3 The potential danger of suboptimal antibody responses in COVID-19
- 5.4 Allerta Variante Delta secondo Ministero della Salute Luglio 21
- 5.5 Variants_of_Concern_VOC_Technical_Briefing_17
- 5.6 covid-19-delta-variant-natural-immunity-pdf
6. Il SENSO di vaccinare i GIOVANI
- 6.1 Immunological_characteristics_gover_the_transition_of_cùCovid_19
- 6.2 COVID-19 in children_ analysis of the first pandemic peak in England
- 6.3 Association between living with children and outcomes from COVID-19_ an OpenSAFELY cohort study of 12 million adults in England
- 6.4 Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults A Systematic Review and Meta-analysis _ Adolescent Medicine _ JAMA Pediatrics _ JAMA Network
- 6.5 Vaccines and sudden infant death- An analysis of the VAERS database 1990–2019 and review of the medical literature – ScienceDirect
7. PREVENZIONE e CURA del COVID-19: terapie domiciliari precoci
- 7.1 Pathophysiological_Basis_and_Rationale_for_Early_Outpatient_Treatment
- 7.2 Multifaceted_highly_targeted_sequential_multidrug_treatment_of
- 7.3 Early_Ambulatory_Multidrug_Therapy_Reduces_Hospitalization_and
- 7.4 Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection
- 7.5 A Guide to Home-Based COVID Treatment
- 7.6 Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection
- 7.7 Ivermectin for COVID-19_ real-time meta analysis of 63 studies
- 7.8 Ivermectin_for_Prevention_and_Treatment_of 7
- 7.9 article in press EClinical Medicine Elsevier 9giugno 2021